Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer
Condition(s):Prostate CancerLast Updated:March 17, 2022Suspended
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:March 17, 2022Suspended
Condition(s):Prostate CancerLast Updated:June 23, 2021Completed
Condition(s):Prostate CarcinomaLast Updated:June 23, 2023Active, not recruiting
Condition(s):Prostate CancerLast Updated:June 2, 2010Terminated
Condition(s):Bone MetastasesLast Updated:November 29, 2012Unknown status
Condition(s):Prostate AdenocarcinomaLast Updated:February 7, 2024Recruiting
Condition(s):Castration-resistant Prostate Cancer Patients With OligometastasesLast Updated:October 20, 2020Recruiting
Condition(s):Cervical Cancer; Endometrial Cancer; Gastrointestinal Complications; Perioperative/Postoperative Complications; Radiation Toxicity; Urinary Complications; Urinary Tract ToxicityLast Updated:June 15, 2022Completed
Condition(s):Solid Tumors; Advanced Triple Negative Breast Cancer; Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer; Advanced Metastatic Castration-Resistant Prostate Cancer; Advanced Platinum-Resistant Ovarian CancerLast Updated:November 30, 2023Terminated
Condition(s):Prostate CancerLast Updated:September 20, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.